EVENTS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 10, 2019 at 11:30 a.m. PT / 2:30 p.m. ET at...
Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 -- Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...
Cancer’s Next-Gen Smart Bomb: Who Will Be First To Weaponize? – InVivo
https://invivo.pharmamedtechbi.com/IV005100/Cancers-NextGen-Smart-Bomb-Who-Will-Be-First-To-Weaponize
Biotechnology: Saving Lives & Transforming Healthcare in the 21st Century
Modern biotechnology is a young industry. But in just a few decades, the entrepreneurs, scientists, researchers and investors working in this field have firmly established themselves at the forefront of medical innovation. Their work is transforming the way we treat –...
BioTech Nation Radio with CEO Bill Newell
NPR and BioTech Nation interview Sutro's CEO William Newell to learn more about the next generation of cancer therapeutics. Click here to listen to the conversation as Bill describes Sutro's discovery and development efforts combining targeted warheads and ADC's in...
Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association
SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ -- Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual Pantheon Ceremony 2015 Presenting DiNA Awards. Late last year, Sutro entered into...
FierceBiotech names Sutro Biopharma as one of its “Fierce 15” Biotech Companies of 2014
San Francisco, CA – September 22, 2014 – Sutro Biopharma today announced that it has been named by FierceBiotech as one of 2014’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry....
Sutro Biopharma’s Xpress CF+™ Technology Nominated for Best Scientific Innovation by World ADC
On July 1, 2014, World ADC announced the nominees for the World ADC Awards, 2014. Sutro Biopharma's cell free expression system, Xpress CF+™, has made the shortlist for nominations in the Best Scientific Innovation category. The award ceremony took place October 26,...
EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology
Press release published by EnWave Corporation regarding the recent agreement with Sutro Biopharma, Inc. Read more
Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter
Scientific American Guest Blog Antibody-Drug Conjugates and Cancer Treatment: Making "Smart Bombs" Smarter By: Trevor J. Hallam Read More
